Last reviewed · How we verify
NCT04733937
Comparative Effects of A2 Platinum Stage 1 Infant Formula on Infant Digestion and Comfort
NA trial testing a2 Platinum® stage 1 infant formula in Healthy Infants in 180 participants. Completed in 16 April 2022.
16 April 2022
Quick facts
| Lead sponsor | a2 Milk Company Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 180 |
| Start date | 7 July 2021 |
| Primary completion | 16 April 2022 |
| Estimated completion | 16 April 2022 |
| Sites | 5 locations across China |
Drugs / interventions tested
- a2 Platinum® stage 1 infant formula
- Conventional, A1 and A2 β-casein containing stage 1 infant formula
Conditions studied
- Healthy Infants — all drugs for Healthy Infants →
Sponsor
a2 Milk Company Ltd.
Who can join
Adults 0 Days to 76 Days, any sex, with Healthy Infants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial is a single-blind, randomized, controlled, parallel-designed trial to compare the effects of a2 Platinum® stage 1 infant formula versus conventional, A1 and A2 β-casein-containing stage 1 infant formula versus breastfeeding on crying, tolerance, gut health, and immune function.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04733937
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Infants
Currently open trials in the same condition.
- NCT07054216 — Probiotic for Infants · NA · recruiting
- NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting
Other a2 Milk Company Ltd. trials
Trials by the same sponsor.
- NCT06256094 — The Effects of a2 Infant Formula on Growth and Tolerance in Healthy Term Infants · NA · completed
- NCT05829720 — Investigate Effects of A2 Milk on Breastmilk Composition and Subsequent Infant Gut Health, Crying and Sleep Patterns in · NA · completed
- NCT05741047 — Comparative Effects of a2 Skim Milk on Mild Cognitive Impairment in Older Adults · NA · completed
- NCT05670678 — Improved Respiratory Infection by Consuming Lactoferrin Fortified a2 Growing up Formula in Children of 2 to 3 Year Old · completed
- NCT06763185 — A1 Beta-casein-free Milk in Milk-intolerant Participants · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04733937 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by a2 Milk Company Ltd.
- Last refreshed: 18 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04733937.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing